A double-blind comparison of naproxen with indomethacin in osteoarthritis.
D000284:Administration, Oral; D000368:Aged; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006621:Hip Joint; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007719:Knee Joint; D008738:Methyl Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009068:Movement; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy* / Q000503:physiopathology; D010919:Placebos; D011422:Propionates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D008738:Methyl Ethers; D009281:Naphthalenes; D010919:Placebos; D011422:Propionates; D007213:Indomethacin